Try GOLD - Free
The constraints and innovations in the packaging of biologic drugs
Express Pharma
|December 2025
Biologic drugs are transforming the treatment of chronic and complex diseases, with Stevanato Group outlining packaging and device platforms for their administration
-
Yet due to the nature of these complex, protein-based therapies, their potential for interaction with packaging materials poses significant challenges for containment and delivery across the supply chain. At the same time, the growing preference for at-home treatment and self-administration is reshaping how patients use and interact with these new therapies.
To keep pace with shifting patient expectations and the complexity of biologic therapies, drug developers are embracing advanced delivery solutions, which are enabling safer, more convenient self-administration with improved drug stability and regulatory compliance.
We look at how modern packaging strategies are evolving to address the twin pressures of technical performance and patient-centric design - and why integrated systems like Alba® syringes, Nexa® syringes, and the Aidaptus® auto-injector are at the forefront of this transformation.
Market dynamics and patient-centric trends
Biologics are becoming increasingly favored for their targeted action and lower side effect profiles in treating complex and chronic diseases - including cancer, autoimmune disorders, and rare conditions - and are supported by advances in biotechnology, and an aging global population. Additionally, the emergence of biosimilars and evolving regulatory frameworks are driving further market expansion and influencing how biologics are developed, delivered, and administered.
A critical challenge in biologic drug development is managing interactions between the product and its primary container. Leachables from materials like glass or silicone, or extractables from adhesives, can trigger protein aggregation or reduce efficacy. In addition, the large and structurally complex nature of biologic molecules makes them highly sensitive to environmental factors - requiring packaging strategies that maintain stability and prevent degradation.
This story is from the December 2025 edition of Express Pharma.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Express Pharma
Express Pharma
The invisible threat: Why packaging inks are the next major recall risk for pharma
Jatin Takkar, Head - Product Safety & Regulatory, Siegwerk India writes that packaging is emerging as a potential source of contamination due to unsafe ink chemistries. With global standards evolving, the industry must shift from reactive compliance to a proactive 'Safe by Design' approach that ensures packaging inks are as safe as the medicines they guard
4 mins
December 2025
Express Pharma
Beyond the machine: How intelligent packaging design elevates parenteral delivery
For sensitive parenteral products, the packaging is as critical as the drug itself. Uhlmann demonstrates how deep design competence turns packaging challenges into patient-centric solutions
2 mins
December 2025
Express Pharma
Ensuring Clean Room Integrity with Prime Clean Reset High-Speed Doors: Minimizing Air Permeability and Leakages
High-speed doors for clean rooms are specialized industrial doors essential for maintaining controlled environments.
3 mins
December 2025
Express Pharma
JULABO introduces Green Edition Refrigerated Circulators using natural refrigerants for sustainable lab cooling
JULABO launches its Green Edition range of refrigerated circulators designed to support laboratories in reducing carbon emissions, improving energy efficiency, and aligning with global environmental regulations
2 mins
December 2025
Express Pharma
Flexotherm Heating Tapes & Cords
Tempo's Flexotherm heating tapes and cords provide a safe, flexible, and efficient solution for maintaining solvent temperature across a wide range of industrial processes
1 mins
December 2025
Express Pharma
PRUV® -The original Sodium Stearyl Fumarate
JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago
5 mins
December 2025
Express Pharma
We continue to invest heavily in quality, regulatory compliance, and modernisation
Rishad Dadachanji, MD, Kaisha Packaging shares insights on emerging industry trends, new technologies showcased at CPhI & P-MEC, and how the Dadachanji Group is strengthening its integrated ecosystem to serve both domestic and global pharma markets
3 mins
December 2025
Express Pharma
Romaco begins local format part production in India
The Noack N 950E blister packaging machine with Indian-produced format parts to debut at CPHI & PMEC India 2025, followed by installation at the Romaco India Experience Centre in Hyderabad
4 mins
December 2025
Express Pharma
We built our business by obsessing over excipients
Shivang Zaveri, Director, Transchem Corporation Pharma; discusses Transchem's approach to excipients, innovation, and market strategy with Express Pharma.
2 mins
December 2025
Express Pharma
India is a cornerstone of Fette Compacting's global strategy
Ashok Gourish, Managing Director, Fette Compacting India, discusses India's pivotal role in the company's global growth, backed by expanded services, digital transformation support, and a strengthened Competence Center in Goa, in conversation with Express Pharma
5 mins
December 2025
Listen
Translate
Change font size
